Odyssey Therapeutics, Inc.

Direct answer

Odyssey Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ODTX.

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small...

Can you invest in Odyssey Therapeutics, Inc.?

Yes. Odyssey Therapeutics, Inc. trades publicly on NASDAQ as ODTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Odyssey Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.